Tammaro2020 Covid 19
Tammaro2020 Covid 19
Tammaro2020 Covid 19
Key words: COVID-19, SARS-CoV-2, skin manifestations, cutaneous, herpetiform lesions, trunk
Figure count: 2
Institutions:
This article has been accepted for publication and undergone full peer review but has not been
through the copyediting, typesetting, pagination and proofreading process, which may lead to
differences between this version and the Version of Record. Please cite this article as doi:
10.1111/JDV.16530
This article is protected by copyright. All rights reserved
5 Clinical Research/Epidemiology in Pneumonia and Sepsis (CRIPS). Vall d’Hebron Institut of
Accepted Article
Research (VHIR), Barcelona, Spain
Corresponding author:
Antonella Tammaro
Email: [email protected]
Conflict of interest:
In December 2019, a new virus called severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) causing Coronavirus disease 2019 (COVID-19) emerged in Wuhan, Hubei Province,
China1–3. SARS-CoV-2 is transmitted through respiratory droplets and object infected with
droplets containing the virus1,2. The diagnosis is made employing quantitative reverse transcriptase
polymerase chain reaction to identify the viral nucleic acid in respiratory specimens or blood
samples2. The symptoms that have been associated to COVID-19 are dry cough, fever, runny nose,
dyspnea, anorexia and even nausea and diarrhea1,2. In severe cases the patients may develop
coagulation dysfunction, acute respiratory distress syndrome (ARDS), arrhythmia and septic
shock1,2.
Since December 2019, the virus has spread in Europe and other regions of the world: Italy and
Spain have been among the most affected countries4,5.
As dermatologists we tried to comprehend the cutaneous involvement in COVID-19 as there is not
much information in this regard in the literature6,7.
We identified and visited 130 patients affected by COVID-19 in Sant’Andrea Hospital in Rome
and 2 (1.5%) of them presented with isolated herpetiform lesions on their trunk that had appeared
during their inpatient stay (Fig.1). Such lesions were characterized by vesicles surrounded by
erythematous halos and were accompanied by mild pruritus. In one of the patients the vesicles had
started to form crusts.
Furthermore, we visited COVID-19 patients in Vall d’Hebron Hospital in Barcelona and found
one patient who presented with numerous vesicular isolated lesions on her back which appeared 8
days after she had been diagnosed with COVID-19 (Fig.2).
The findings of the report from Lecco Hospital are in line with the ones that we found. However,
more studies should be performed to investigate the nature of the relation between the appearance
of skin lesions, in particular chickenpox-like manifestations, and COVID-19.
Acknowledgments: The patients in this manuscript have given written informed consent to
publication of their case details
References
2. Yang P, Wang X. COVID-19: a new challenge for human beings. Cell Mol Immunol. 2020;1–
3.
3. Wu F, Zhao S, Yu B, Chen Y-M, Wang W, Song Z-G, et al. A new coronavirus associated
with human respiratory disease in China. Nature. 2020;579(7798):265–9.
5. Novel Coronavirus (2019-nCoV) situation reports [Internet]. [cited 2020 Apr 5]. Available
from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports
7. Zheng Y, Lai W. Dermatology staff participate in fight against Covid-19 in China. J Eur Acad
Dermatol Venereol JEADV. 2020;
Legends
jdv_16530_f2.tif